Regulus Therapeutics (RGLS): Q4 EPS of -$0.22 misses by $0.15. Revenue of $3.2M misses by $0.1M....

|About: Regulus Therapeutics (RGLS)|By:, SA News Editor
Regulus Therapeutics (RGLS): Q4 EPS of -$0.22 misses by $0.15. Revenue of $3.2M misses by $0.1M. (PR)